News MS Rehabilitation Specialist, Susan Bennett, Receives Lifetime Achievement Award from CMSC MS Rehabilitation Specialist, Susan Bennett, Receives Lifetime Achievement Award from CMSC by Patricia Silva, PhD | July 19, 2016 Share this article: Share article via email Copy article link Susan Bennett, left, clinical professor of rehabilitation science at the University at Buffalo, poses with June Halper of the CMSC after receiving the group's Lifetime Achievement Award in June. (Credit: University at Buffalo) The Consortium of Multiple Sclerosis Centers (CMSC)Ā has awarded Susan E. BennettĀ one of its highest honors, the Lifetime Achievement Award. Bennett, a clinical professor of rehabilitation science at the University at BuffaloĀ and pioneer in the field of MS rehabilitation, was honored for her achievements in advancing care for multiple sclerosis patients since the 1990s. She is the first rehabilitation professional to receive this recognition by the CMSC. The award was presented at the CMSC 2016 meeting by June Halper, the group’s CEO. CMSC represents over 10,000 healthcare professionals across the globe providing care for peopleĀ with multiple sclerosis. āThis is the first time that an individual from the rehabilitation field has received this award,ā Halper said in a news release.Ā āSue Bennett is a pioneer in rehabilitation practices and the role it plays in the comprehensive care of neurological disorders, especially with MS. She has also been an invaluable leader and role model for CMSC, and her unwavering commitment to enhancing the care and quality of life of people with MS, and their families, reflects the highest ideals of the CMSC and all of our allied organizations.ā Susan Bennett, left, clinical professor of rehabilitation science at the University at Buffalo, after receiving the Lifetime Achievement Award from the CMSC. With her is June Halper, the group’s CEO. (Credit: University at Buffalo) āItās a special honor to be the first rehabilitation professional to receive the award. It caught me totally off guard. Itās one of the highest awards Iāve ever received in my professional career,ā said Bennett. At the presentation, Bennett thanked both Lawrence Jacobs and Frederick Muncshauer for being her mentors. Muncshauer is now vice president of neurology and immunology for EMD Serono biopharmaceuticals, continuing his commitment to searching for a cure forĀ multiple sclerosis. Bennett also notedĀ the progress made over the past two decades in the care ofĀ MS patients. āWe have come so far from 1995, when we never thought of rehabilitation in MS. We never thought of exercise in MS,ā she said. āIt was āGo home, rest, donāt overheat, donāt overstress yourself.ā And of course the patients got worse because of disuse atrophy.ā Bennett is also aĀ clinical professor in the Department of Neurology atĀ the Jacobs School of Medicine and Biomedical Sciences, and a physical therapist with UB Neurosurgery (UBMD Physicians Group). She runs the Bennett Rehabilitation Institute, her own practice, which she opened in 1992, and she served as CMSC president from 2012 to 2014. āThe consortium is what itās about. Itās about comprehensive care, all of us working together to advance quality of life and the functionality of our patients,ā Bennett added. She currently serves as project director for the Rehabilitation Fellowship Group and is chair of the CMSC Rehabilitation Research Interest Group. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags CMSC, Consortium of Multiple Sclerosis Centers, rehabilitation, University at Buffalo
April 22, 2024 News by Marisa Wexler, MS AAN 2024: Briumvi found to ease disability in certain MS patients
April 22, 2024 Columns by Desiree Lama Learning to manage cognitive impairment with multiple sclerosis
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Earlier Ocrevus lowers MS progression risk over 10 years